Review




Structured Review

MyBiosource Biotechnology cr elisa kit
Cr Elisa Kit, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cr elisa kit/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
cr elisa kit - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

93
Biorbyt human creatinine cr elisa kit
Human Creatinine Cr Elisa Kit, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human creatinine cr elisa kit/product/Biorbyt
Average 93 stars, based on 1 article reviews
human creatinine cr elisa kit - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
AFG Bioscience LLC mouse creatinine (cr) elisa kit
( A ) TSP-1 protects FB from cleavage by FD. FB was incubated with FD, C3b, and varying concentrations of TSP-1. Subsequently, FB and its cleavage products were visualized by Coomassie blue staining. Graph on the right illustrates band intensity of FB and its cleavage products. ( B ) TSP-1 inhibits cleavage of C3 by the alternative complement pathway C3 convertase. C3 convertase was generated by incubating C3(H2O) with FB and FD, followed by the addition of C3 in the presence or absence of TSP-1 or FH. As a positive control, CVF C3 convertase (CVF + FB + FD) was utilized. The graph on the right depicts the band intensity of C3-α′ chain. Lanes were run on the same gel but were noncontiguous. Data are shown as mean ± SD. ( C ) TSP-1 inhibits cleavage of C5. Cobra venom factor (CVF) convertase (CVFBb) was generated and added to C5 preincubated with FH, eculizumab, MFHR1, or TSP-1. The amount of released C5a was quantified by <t>ELISA.</t> Data are shown as mean ± SD. ANOVA was used with Dunnett’s multiple-comparison test. ( D ) TSP-1 inhibits the formation of MAC. Sheep erythrocytes were premixed with C7 (9 nM), C8 (7 nM), and C9 (15 nM). BSA, eculizumab, MFHR1, or TSP-1 (1.3 μM each) were preincubated with C5b-6 (0.7 nM) and then added to the erythrocytes. Data are shown as mean ± SD of 3 independent experiments; ** P ≤ 0.01, *** P ≤ 0.01; 1-way ANOVA was used with Tukey’s post hoc test for comparison against control.
Mouse Creatinine (Cr) Elisa Kit, supplied by AFG Bioscience LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse creatinine (cr) elisa kit/product/AFG Bioscience LLC
Average 90 stars, based on 1 article reviews
mouse creatinine (cr) elisa kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Nanjing Jiancheng Bioengineering Research Institute Co Ltd enzyme-linked immunosorbent assay (elisa) kit (creatinine(cr)
( A ) TSP-1 protects FB from cleavage by FD. FB was incubated with FD, C3b, and varying concentrations of TSP-1. Subsequently, FB and its cleavage products were visualized by Coomassie blue staining. Graph on the right illustrates band intensity of FB and its cleavage products. ( B ) TSP-1 inhibits cleavage of C3 by the alternative complement pathway C3 convertase. C3 convertase was generated by incubating C3(H2O) with FB and FD, followed by the addition of C3 in the presence or absence of TSP-1 or FH. As a positive control, CVF C3 convertase (CVF + FB + FD) was utilized. The graph on the right depicts the band intensity of C3-α′ chain. Lanes were run on the same gel but were noncontiguous. Data are shown as mean ± SD. ( C ) TSP-1 inhibits cleavage of C5. Cobra venom factor (CVF) convertase (CVFBb) was generated and added to C5 preincubated with FH, eculizumab, MFHR1, or TSP-1. The amount of released C5a was quantified by <t>ELISA.</t> Data are shown as mean ± SD. ANOVA was used with Dunnett’s multiple-comparison test. ( D ) TSP-1 inhibits the formation of MAC. Sheep erythrocytes were premixed with C7 (9 nM), C8 (7 nM), and C9 (15 nM). BSA, eculizumab, MFHR1, or TSP-1 (1.3 μM each) were preincubated with C5b-6 (0.7 nM) and then added to the erythrocytes. Data are shown as mean ± SD of 3 independent experiments; ** P ≤ 0.01, *** P ≤ 0.01; 1-way ANOVA was used with Tukey’s post hoc test for comparison against control.
Enzyme Linked Immunosorbent Assay (Elisa) Kit (Creatinine(Cr), supplied by Nanjing Jiancheng Bioengineering Research Institute Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/enzyme-linked immunosorbent assay (elisa) kit (creatinine(cr)/product/Nanjing Jiancheng Bioengineering Research Institute Co Ltd
Average 90 stars, based on 1 article reviews
enzyme-linked immunosorbent assay (elisa) kit (creatinine(cr) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Nanjing Jiancheng Bioengineering Research Institute Co Ltd elisa kits for relevant biomarkers (mda, cr, bun, alt, ast, gsh)
( A ) TSP-1 protects FB from cleavage by FD. FB was incubated with FD, C3b, and varying concentrations of TSP-1. Subsequently, FB and its cleavage products were visualized by Coomassie blue staining. Graph on the right illustrates band intensity of FB and its cleavage products. ( B ) TSP-1 inhibits cleavage of C3 by the alternative complement pathway C3 convertase. C3 convertase was generated by incubating C3(H2O) with FB and FD, followed by the addition of C3 in the presence or absence of TSP-1 or FH. As a positive control, CVF C3 convertase (CVF + FB + FD) was utilized. The graph on the right depicts the band intensity of C3-α′ chain. Lanes were run on the same gel but were noncontiguous. Data are shown as mean ± SD. ( C ) TSP-1 inhibits cleavage of C5. Cobra venom factor (CVF) convertase (CVFBb) was generated and added to C5 preincubated with FH, eculizumab, MFHR1, or TSP-1. The amount of released C5a was quantified by <t>ELISA.</t> Data are shown as mean ± SD. ANOVA was used with Dunnett’s multiple-comparison test. ( D ) TSP-1 inhibits the formation of MAC. Sheep erythrocytes were premixed with C7 (9 nM), C8 (7 nM), and C9 (15 nM). BSA, eculizumab, MFHR1, or TSP-1 (1.3 μM each) were preincubated with C5b-6 (0.7 nM) and then added to the erythrocytes. Data are shown as mean ± SD of 3 independent experiments; ** P ≤ 0.01, *** P ≤ 0.01; 1-way ANOVA was used with Tukey’s post hoc test for comparison against control.
Elisa Kits For Relevant Biomarkers (Mda, Cr, Bun, Alt, Ast, Gsh), supplied by Nanjing Jiancheng Bioengineering Research Institute Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kits for relevant biomarkers (mda, cr, bun, alt, ast, gsh)/product/Nanjing Jiancheng Bioengineering Research Institute Co Ltd
Average 90 stars, based on 1 article reviews
elisa kits for relevant biomarkers (mda, cr, bun, alt, ast, gsh) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ACROBiosystems il-6 human elisa kit crs-b001-96tests
( A ) TSP-1 protects FB from cleavage by FD. FB was incubated with FD, C3b, and varying concentrations of TSP-1. Subsequently, FB and its cleavage products were visualized by Coomassie blue staining. Graph on the right illustrates band intensity of FB and its cleavage products. ( B ) TSP-1 inhibits cleavage of C3 by the alternative complement pathway C3 convertase. C3 convertase was generated by incubating C3(H2O) with FB and FD, followed by the addition of C3 in the presence or absence of TSP-1 or FH. As a positive control, CVF C3 convertase (CVF + FB + FD) was utilized. The graph on the right depicts the band intensity of C3-α′ chain. Lanes were run on the same gel but were noncontiguous. Data are shown as mean ± SD. ( C ) TSP-1 inhibits cleavage of C5. Cobra venom factor (CVF) convertase (CVFBb) was generated and added to C5 preincubated with FH, eculizumab, MFHR1, or TSP-1. The amount of released C5a was quantified by <t>ELISA.</t> Data are shown as mean ± SD. ANOVA was used with Dunnett’s multiple-comparison test. ( D ) TSP-1 inhibits the formation of MAC. Sheep erythrocytes were premixed with C7 (9 nM), C8 (7 nM), and C9 (15 nM). BSA, eculizumab, MFHR1, or TSP-1 (1.3 μM each) were preincubated with C5b-6 (0.7 nM) and then added to the erythrocytes. Data are shown as mean ± SD of 3 independent experiments; ** P ≤ 0.01, *** P ≤ 0.01; 1-way ANOVA was used with Tukey’s post hoc test for comparison against control.
Il 6 Human Elisa Kit Crs B001 96tests, supplied by ACROBiosystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il-6 human elisa kit crs-b001-96tests/product/ACROBiosystems
Average 90 stars, based on 1 article reviews
il-6 human elisa kit crs-b001-96tests - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Nanjing Jiancheng Bioengineering Research Institute Co Ltd elisa kit of creatinine (cr)
( A ) TSP-1 protects FB from cleavage by FD. FB was incubated with FD, C3b, and varying concentrations of TSP-1. Subsequently, FB and its cleavage products were visualized by Coomassie blue staining. Graph on the right illustrates band intensity of FB and its cleavage products. ( B ) TSP-1 inhibits cleavage of C3 by the alternative complement pathway C3 convertase. C3 convertase was generated by incubating C3(H2O) with FB and FD, followed by the addition of C3 in the presence or absence of TSP-1 or FH. As a positive control, CVF C3 convertase (CVF + FB + FD) was utilized. The graph on the right depicts the band intensity of C3-α′ chain. Lanes were run on the same gel but were noncontiguous. Data are shown as mean ± SD. ( C ) TSP-1 inhibits cleavage of C5. Cobra venom factor (CVF) convertase (CVFBb) was generated and added to C5 preincubated with FH, eculizumab, MFHR1, or TSP-1. The amount of released C5a was quantified by <t>ELISA.</t> Data are shown as mean ± SD. ANOVA was used with Dunnett’s multiple-comparison test. ( D ) TSP-1 inhibits the formation of MAC. Sheep erythrocytes were premixed with C7 (9 nM), C8 (7 nM), and C9 (15 nM). BSA, eculizumab, MFHR1, or TSP-1 (1.3 μM each) were preincubated with C5b-6 (0.7 nM) and then added to the erythrocytes. Data are shown as mean ± SD of 3 independent experiments; ** P ≤ 0.01, *** P ≤ 0.01; 1-way ANOVA was used with Tukey’s post hoc test for comparison against control.
Elisa Kit Of Creatinine (Cr), supplied by Nanjing Jiancheng Bioengineering Research Institute Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kit of creatinine (cr)/product/Nanjing Jiancheng Bioengineering Research Institute Co Ltd
Average 90 stars, based on 1 article reviews
elisa kit of creatinine (cr) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Beyotime mouse crea (cr) elisa kit
( A ) TSP-1 protects FB from cleavage by FD. FB was incubated with FD, C3b, and varying concentrations of TSP-1. Subsequently, FB and its cleavage products were visualized by Coomassie blue staining. Graph on the right illustrates band intensity of FB and its cleavage products. ( B ) TSP-1 inhibits cleavage of C3 by the alternative complement pathway C3 convertase. C3 convertase was generated by incubating C3(H2O) with FB and FD, followed by the addition of C3 in the presence or absence of TSP-1 or FH. As a positive control, CVF C3 convertase (CVF + FB + FD) was utilized. The graph on the right depicts the band intensity of C3-α′ chain. Lanes were run on the same gel but were noncontiguous. Data are shown as mean ± SD. ( C ) TSP-1 inhibits cleavage of C5. Cobra venom factor (CVF) convertase (CVFBb) was generated and added to C5 preincubated with FH, eculizumab, MFHR1, or TSP-1. The amount of released C5a was quantified by <t>ELISA.</t> Data are shown as mean ± SD. ANOVA was used with Dunnett’s multiple-comparison test. ( D ) TSP-1 inhibits the formation of MAC. Sheep erythrocytes were premixed with C7 (9 nM), C8 (7 nM), and C9 (15 nM). BSA, eculizumab, MFHR1, or TSP-1 (1.3 μM each) were preincubated with C5b-6 (0.7 nM) and then added to the erythrocytes. Data are shown as mean ± SD of 3 independent experiments; ** P ≤ 0.01, *** P ≤ 0.01; 1-way ANOVA was used with Tukey’s post hoc test for comparison against control.
Mouse Crea (Cr) Elisa Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse crea (cr) elisa kit/product/Beyotime
Average 90 stars, based on 1 article reviews
mouse crea (cr) elisa kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology cr elisa kit
( A ) TSP-1 protects FB from cleavage by FD. FB was incubated with FD, C3b, and varying concentrations of TSP-1. Subsequently, FB and its cleavage products were visualized by Coomassie blue staining. Graph on the right illustrates band intensity of FB and its cleavage products. ( B ) TSP-1 inhibits cleavage of C3 by the alternative complement pathway C3 convertase. C3 convertase was generated by incubating C3(H2O) with FB and FD, followed by the addition of C3 in the presence or absence of TSP-1 or FH. As a positive control, CVF C3 convertase (CVF + FB + FD) was utilized. The graph on the right depicts the band intensity of C3-α′ chain. Lanes were run on the same gel but were noncontiguous. Data are shown as mean ± SD. ( C ) TSP-1 inhibits cleavage of C5. Cobra venom factor (CVF) convertase (CVFBb) was generated and added to C5 preincubated with FH, eculizumab, MFHR1, or TSP-1. The amount of released C5a was quantified by <t>ELISA.</t> Data are shown as mean ± SD. ANOVA was used with Dunnett’s multiple-comparison test. ( D ) TSP-1 inhibits the formation of MAC. Sheep erythrocytes were premixed with C7 (9 nM), C8 (7 nM), and C9 (15 nM). BSA, eculizumab, MFHR1, or TSP-1 (1.3 μM each) were preincubated with C5b-6 (0.7 nM) and then added to the erythrocytes. Data are shown as mean ± SD of 3 independent experiments; ** P ≤ 0.01, *** P ≤ 0.01; 1-way ANOVA was used with Tukey’s post hoc test for comparison against control.
Cr Elisa Kit, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cr elisa kit/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
cr elisa kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology mouse creatinine (cr) elisa kit
( A ) TSP-1 protects FB from cleavage by FD. FB was incubated with FD, C3b, and varying concentrations of TSP-1. Subsequently, FB and its cleavage products were visualized by Coomassie blue staining. Graph on the right illustrates band intensity of FB and its cleavage products. ( B ) TSP-1 inhibits cleavage of C3 by the alternative complement pathway C3 convertase. C3 convertase was generated by incubating C3(H2O) with FB and FD, followed by the addition of C3 in the presence or absence of TSP-1 or FH. As a positive control, CVF C3 convertase (CVF + FB + FD) was utilized. The graph on the right depicts the band intensity of C3-α′ chain. Lanes were run on the same gel but were noncontiguous. Data are shown as mean ± SD. ( C ) TSP-1 inhibits cleavage of C5. Cobra venom factor (CVF) convertase (CVFBb) was generated and added to C5 preincubated with FH, eculizumab, MFHR1, or TSP-1. The amount of released C5a was quantified by <t>ELISA.</t> Data are shown as mean ± SD. ANOVA was used with Dunnett’s multiple-comparison test. ( D ) TSP-1 inhibits the formation of MAC. Sheep erythrocytes were premixed with C7 (9 nM), C8 (7 nM), and C9 (15 nM). BSA, eculizumab, MFHR1, or TSP-1 (1.3 μM each) were preincubated with C5b-6 (0.7 nM) and then added to the erythrocytes. Data are shown as mean ± SD of 3 independent experiments; ** P ≤ 0.01, *** P ≤ 0.01; 1-way ANOVA was used with Tukey’s post hoc test for comparison against control.
Mouse Creatinine (Cr) Elisa Kit, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse creatinine (cr) elisa kit/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
mouse creatinine (cr) elisa kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


( A ) TSP-1 protects FB from cleavage by FD. FB was incubated with FD, C3b, and varying concentrations of TSP-1. Subsequently, FB and its cleavage products were visualized by Coomassie blue staining. Graph on the right illustrates band intensity of FB and its cleavage products. ( B ) TSP-1 inhibits cleavage of C3 by the alternative complement pathway C3 convertase. C3 convertase was generated by incubating C3(H2O) with FB and FD, followed by the addition of C3 in the presence or absence of TSP-1 or FH. As a positive control, CVF C3 convertase (CVF + FB + FD) was utilized. The graph on the right depicts the band intensity of C3-α′ chain. Lanes were run on the same gel but were noncontiguous. Data are shown as mean ± SD. ( C ) TSP-1 inhibits cleavage of C5. Cobra venom factor (CVF) convertase (CVFBb) was generated and added to C5 preincubated with FH, eculizumab, MFHR1, or TSP-1. The amount of released C5a was quantified by ELISA. Data are shown as mean ± SD. ANOVA was used with Dunnett’s multiple-comparison test. ( D ) TSP-1 inhibits the formation of MAC. Sheep erythrocytes were premixed with C7 (9 nM), C8 (7 nM), and C9 (15 nM). BSA, eculizumab, MFHR1, or TSP-1 (1.3 μM each) were preincubated with C5b-6 (0.7 nM) and then added to the erythrocytes. Data are shown as mean ± SD of 3 independent experiments; ** P ≤ 0.01, *** P ≤ 0.01; 1-way ANOVA was used with Tukey’s post hoc test for comparison against control.

Journal: The Journal of Clinical Investigation

Article Title: Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis

doi: 10.1172/JCI180062

Figure Lengend Snippet: ( A ) TSP-1 protects FB from cleavage by FD. FB was incubated with FD, C3b, and varying concentrations of TSP-1. Subsequently, FB and its cleavage products were visualized by Coomassie blue staining. Graph on the right illustrates band intensity of FB and its cleavage products. ( B ) TSP-1 inhibits cleavage of C3 by the alternative complement pathway C3 convertase. C3 convertase was generated by incubating C3(H2O) with FB and FD, followed by the addition of C3 in the presence or absence of TSP-1 or FH. As a positive control, CVF C3 convertase (CVF + FB + FD) was utilized. The graph on the right depicts the band intensity of C3-α′ chain. Lanes were run on the same gel but were noncontiguous. Data are shown as mean ± SD. ( C ) TSP-1 inhibits cleavage of C5. Cobra venom factor (CVF) convertase (CVFBb) was generated and added to C5 preincubated with FH, eculizumab, MFHR1, or TSP-1. The amount of released C5a was quantified by ELISA. Data are shown as mean ± SD. ANOVA was used with Dunnett’s multiple-comparison test. ( D ) TSP-1 inhibits the formation of MAC. Sheep erythrocytes were premixed with C7 (9 nM), C8 (7 nM), and C9 (15 nM). BSA, eculizumab, MFHR1, or TSP-1 (1.3 μM each) were preincubated with C5b-6 (0.7 nM) and then added to the erythrocytes. Data are shown as mean ± SD of 3 independent experiments; ** P ≤ 0.01, *** P ≤ 0.01; 1-way ANOVA was used with Tukey’s post hoc test for comparison against control.

Article Snippet: The following ELISAs and sample dilutions were used in this study: mouse albumin ELISA kit (1:500.000, Crystal Chem, 80630), mouse creatinine (Cr) ELISA kit (1:10, AFG Scientific, EK734005 ), mouse complement C3 ELISA kit (1:300, Abcam, AB157711 ), mouse Cit H3 ELISA kit (1:10, Biorbyt, ORB1496437), mouse C5a ELISA kit (1:25, Antikoerper Online, ABIN6720057), and mouse TSP-1 (THBS1) ELISA kit (1:60, Biozol, ABX575980).

Techniques: Incubation, Staining, Generated, Positive Control, Combined Bisulfite Restriction Analysis Assay, Enzyme-linked Immunosorbent Assay, Comparison, Control